Related Experiment Videos
Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix.
Sam J Kuhn1, Stephanie K Finch, Dennis E Hallahan
1Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, USA.
Nano Letters
|February 9, 2006
Summary
Superparamagnetic nanoparticles coated with collagenase can penetrate extracellular matrix barriers, enabling therapeutic agent delivery. This novel approach maintains enzyme stability and facilitates tissue biodistribution for improved nanoparticle therapeutics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Steric barriers, primarily collagen I, impede the interstitial delivery of macromolecular and nanoparticle (NP)-based therapeutic agents.
- Effective delivery of therapeutics to target tissues is a significant challenge in nanomedicine.
Purpose of the Study:
- To overcome extracellular matrix (ECM) barriers for enhanced therapeutic agent delivery using modified nanoparticles.
- To investigate the efficacy of collagenase-linked superparamagnetic NPs in navigating the interstitial space.
Main Methods:
- Development of superparamagnetic nanoparticles conjugated with collagenase.
- In vitro assessment of NP migration through extracellular matrix (ECM) under magnetic field influence.
- Evaluation of proteolytic enzyme stability and NP migration over time.
Main Results:
- Collagenase-linked superparamagnetic NPs successfully navigated the in vitro ECM at a rate of 90 microm h⁻¹, comparable to invasive cells.
- NP migration in the ECM showed a linear decrease over a 5-day period.
- The collagenase-NP construct demonstrated sustained enzyme stability and effective degradation of interstitial barriers.
Conclusions:
- Immobilized collagenase on NP surfaces maintains proteolytic enzyme stability for clinically relevant durations.
- Conjugated microbial proteases enable the degradation of interstitial barriers, facilitating improved tissue biodistribution of nano- and microscale therapeutics.
- This approach presents a promising strategy for overcoming key delivery challenges in nanoparticle-based therapies.